Durvalumab-Induced Demyelinating Lesions in a Patient With Extensive-Stage Small-Cell Lung Cancer: A Case Report

• Principais autores: Wenhui Liu (Autor), Bo Chen (Autor), Yiping Liu (Autor), Zhiying Luo (Autor), Bao Sun (Autor), Fang Ma (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

It is of great clinical value to investigate the immune-related adverse events (irAEs), especially demyelinating lesions, caused by immune checkpoint inhibitors (ICIs). The incidence of demyelinating lesions is less frequent in irAEs, but once it occurs, it will seriously affect the survival of pati...